---
title: "景順投資管理有限公司：表格 8.3 - 英傑華 (ADR)；公開交易披露"
description: "景順投資管理有限公司：第 8.3 號表格 - 英傑華 (ADR)；公開交易披露"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/221795459.md"
published_at: "2024-12-09T11:06:51.000Z"
---

# 景順投資管理有限公司：表格 8.3 - 英傑華 (ADR)；公開交易披露

> 景順投資管理有限公司：第 8.3 號表格 - 英傑華 (ADR)；公開交易披露

**PUBLIC DEALING DISCLOSURE** **BY**  
**A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE**  
**Rule 8.3 of the Takeover Code (the “Code”)**

**1.****KEY INFORMATION** **(a)****Full name of discloser:**Invesco Ltd. **(b)****Owner or controller of interests and short positions disclosed, if different from 1(a):**  
*The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.* **(c)****Name of offeror/offeree in relation to whose relevant securities this form relates:**  
*Use a separate form for each offeror/offeree*Aviva PLC **(d)****If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:** **(e)****Date position held/dealing undertaken:**  
*For an opening position disclosure, state the latest practicable date prior to the disclosure*06.12.2024 **(f)****In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?**  
*If it is a cash offer or possible cash offer, state “N/A”*Yes, Direct Line Insurance Group PLC **2.****POSITIONS OF THE PERSON MAKING THE DISCLOSURE** *If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.* **(a)****Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)** **Class of relevant security:****32 17/19p ordinary** **GB00BPQY8M80 & ADR US05382A3023** **Interests****Short Positions** **Number****%****Number****%** **(1)****Relevant securities owned and/or controlled:**44,620,2551.66 **(2)****Cash-settled derivatives:** **(3)****Stock-settled derivatives (including options) and agreements to purchase/sell:** **Total**44,620,2551.66 *All interests and all short positions should be disclosed.*

*Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).*

**(b)****Rights to subscribe for new securities (including directors’ and other employee options)** **Class of relevant security in relation to which subscription right exists:** **Details, including nature of the rights concerned and relevant percentages:** **3.****DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE** *Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.*

*The currency of all prices and other monetary amounts should be stated.*

**(a)****Purchases and sales** **Class of relevant security****Purchase/sale****Number of securities****Price per unit** 32 17/19p ordinary GB00BPQY8M80Purchase2,9314.84 GBP 32 17/19p ordinary GB00BPQY8M80Purchase1,4374.88 GBP 32 17/19p ordinary GB00BPQY8M80Sale3184.84 GBP **(b)****Cash-settled derivative transactions** **Class of relevant security****Product description** *e.g. CFD***Nature of dealing** *e.g. opening/closing a long/short position, increasing/reducing a long/short position***Number of reference securities****Price per unit** **(c)****Stock-settled derivative transactions (including options)** **(i)****Writing, selling, purchasing or varying** **Class of relevant security****Product description** *e.g. call option***Writing, purchasing, selling, varying etc.****Number of securities to which option relates****Exercise price per unit****Type** *e.g. American, European etc.***Expiry date****Option money paid/ received per unit** **(ii)****Exercise** **Class of relevant security****Product description** *e.g. call option***Exercising/ exercised against****Number of securities****Exercise price per unit** **(d)****Other dealings (including subscribing for new securities)** **Class of relevant security****Nature of dealing** *e.g. subscription, conversion***Details****Price per unit (if applicable)** **4.****OTHER INFORMATION** **(a)****Indemnity and other dealing arrangements** **Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:**  
*Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”* None **(b)****Agreements, arrangements, or understandings relating to options or derivatives** **Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:**  
**(i) the voting rights of any relevant securities under any option; or**  
**(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:**  
*If there are no such agreements, arrangements or understandings, state “none”* None **Is a Supplemental Form 8 (Open Positions) attached?**NO **Date of disclosure**09.12.2024 **Contact name**Philippa Holmes **Telephone number**+441491417447

*Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.*

*The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0) 20 7638 0129.*

*The Code can be viewed on the Panel’s website at* *www.thetakeoverpanel.org.uk**.*

### Related Stocks

- [IVZ.US - 景順投資管理](https://longbridge.com/zh-HK/quote/IVZ.US.md)
- [AVVIY.US - 英傑華(ADR)](https://longbridge.com/zh-HK/quote/AVVIY.US.md)
- [FORM.US - Formfactor](https://longbridge.com/zh-HK/quote/FORM.US.md)
- [AV.UK - 英傑華集團](https://longbridge.com/zh-HK/quote/AV.UK.md)
- [IP.US - International Paper](https://longbridge.com/zh-HK/quote/IP.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| REG - Invesco II 美国国债 10 年以上 - 净资产价值 | 景顺美国国债 10 年以上 UCITS ETF 截至 2026 年 2 月 17 日报告的净资产值（NAV）为 11,706,123.37 美元，每股净资产值为 4.948 美元。该基金发行了 2,365,787 股，此信息由伦敦证券交易所 | [Link](https://longbridge.com/zh-HK/news/276212812.md) |
| 景顺投资管理｜8-K：2025 财年 Q4 营收 16.92 亿美元 |  | [Link](https://longbridge.com/zh-HK/news/273838507.md) |
| REG - 景顺工业标准普尔 - 净资产价值 | 景顺投资管理工业类 S&P 美国精选行业 UCITS ETF 截至 2026 年 2 月 19 日报告每股净资产值（NAV）为 974.4006 美元，发行总股数为 148,711 股。该信息由伦敦证券交易所的新闻服务 RNS 提供，经过金 | [Link](https://longbridge.com/zh-HK/news/276431698.md) |
| REG - IVZ II 2030 USD A $ - 净资产价值 | 景顺投资管理 BulletShares 2030 美元企业债券 UCITS ETF 报告的净资产值（NAV）为 27,616,705.90 美元，每股净资产值为 5.557 美元。该基金已发行 4,969,469 股，相关信息由伦敦证券交易 | [Link](https://longbridge.com/zh-HK/news/276211122.md) |
| REG - IVZ HealthS&PUS - 净资产值 | 景顺医疗保健 S&P 美国精选行业 UCITS ETF 截至 2026 年 2 月 19 日报告每股净资产值（NAV）为 774.9254 美元，发行总股数为 527,565 股。该信息由伦敦证券交易所的新闻服务 RNS 提供，经过金融行为 | [Link](https://longbridge.com/zh-HK/news/276431715.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
